The Food and Drug Administration denied an emergency use authorization for fluvoxamine as a SARS-CoV-2 antiviral.
Subscribe to:
Post Comments (Atom)
< + > Beyond the Science by Gary Zammit – Life Sciences Today Podcast Episode 46
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gary Zammit, PhD,...
No comments:
Post a Comment